See more
Does Sanofi have a patient assistance program?
Sanofi Patient Connection® is a program (the “Program”) to help you get access to the medications and resources you need at no cost. Patient Assistance Connection is part of the Program that provides select Sanofi prescription medications and vaccines, at no cost, if you meet certain eligibility requirements.
Does Pfizer have a patient assistance program?
patients in need get access to their Pfizer medicines. Today, Pfizer RxPathways® connects eligible U.S. patients to a range of Pfizer assistance programs that provide insurance support, co-pay help, and medicines for free or at a savings.
What drugs does Sanofi Aventis make?
Adlyxin (Lixisenatide), for type 2 diabetes mellitus.Admelog (insulin lispro), for type 1 and type 2 diabetes mellitus.Afrezza (Inhalable insulin), for type 1 and type 2 diabetes mellitus.Amaryl (Glimepiride), for type 2 diabetes mellitus.Apidra (insulin glulisine), for type 1 and type 2 diabetes mellitus.More items...
Does Sanofi make opioids?
Sanofi Active Ingredient Solutions provides opiates in forms ranging from poppy seeds to APIs. The company's portfolio comprises 15 opiate APIs with applications in agronomic research, industrial and agricultural production, and distribution.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
Does Viatris have a patient assistance program?
The Viatris Patient Assistance Program provides certain medicines for free to patients with demonstrated financial need. Viatris is committed to helping patients get the treatments they need, when and where they need them.
Who owns Sanofi-Aventis?
Sanofi originated in 1973 as a subsidiary of French petrochemical firm Elf Aquitaine (acquired by Total in 2000). Synthélabo, another pharmaceutical firm, was founded in 1970.
Is Sanofi a big company?
French multinational pharmaceutical giant, Sanofi, is the ninth largest pharmaceutical company in the world by revenue. Sanofi provides healthcare solutions to over 100 countries worldwide and has three core focuses: speciality care, vaccines, and general medicines.
What is Sanofi tablets used for?
Pheniramine Maleate (Sanofi) 25 mg Tablet is an antihistamine with a little sedative action. It is used to prevent or treat allergic reactions like hay fever or a common cold, or other upper respiratory allergies caused external allergens. It is also used as prophylactic medicine for motion sickness.
What is Sanofi most known for?
Sanofi-Synthélabo is known for creating meningitis treatment, Menactra, diabetes treatment Lantus, colorectal cancer drug Eloxatin, and lung, prostate and breast cancer drug Taxorete.
Where is Sanofi located in the US?
Bridgewater, New JerseyHeadquartered in Bridgewater, New Jersey, Sanofi in the United States employs more than 12,500 professionals throughout the country.
Where are Sanofi drugs manufactured?
Kansas City, MOManufacturing Site: Sanofi-aventis manufactures pharmaceutical products in Kansas City, MO.
Which Pfizer blood pressure medication is being recalled?
The drugs in the Pfizer recall include certain batches of Accupril (quinapril hydrochloride) tablets and Accuretic (quinapril hydrochloride plus hydrochlorothiazide) tablets distributed by Pfizer, as well as two related generic formulations distributed by Greenstone.
What is Pfizer enCompass?
The Pfizer enCompass Co-Pay Assistance Program provides assistance for out-of-pocket drug costs associated with INFLECTRA due to co-pays, co-insurances, or deductibles, up to $20,000 per calendar year.
What is Pfizer PAP connect?
Pfizer PAP Connect is designed to simplify how patients can access certain Pfizer medicines through the Pfizer Patient Assistance Program (PAP).
What is Xelsource?
Psoriatic Arthritis. • XELJANZ/XELJANZ XR (tofacitinib) is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).